Infection Control News

The CDC has recommended that infants be immunized with a monoclonal antibody against respiratory syncytial virus.

This fall, older adults in the United States will have the opportunity to receive three vaccines to against fall and winter season respiratory illnesses — COVID-19, influenza and respiratory syncytial virus. 

Nearly one in five U.S. cases of leprosy is reported in Florida, with roughly 81% of cases in the state reported in central Florida, according to a study.

Researchers confirmed the dosing of an ART combination designed to treat children with HIV and found that it was safe, well tolerated and efficacious through 24 weeks, according to results published in The Lancet HIV.

This coming fall and winter, older adults in the United States will face a decision: Should they roll up their sleeves to receive the world’s first approved vaccines against respiratory syncytial virus?

One in six toddlers in the United States did not complete the vaccination series for seven recommended childhood vaccines in 2019, the year before the COVID-19 pandemic, according to a study published in Pediatrics.

Long-acting injectable cabotegravir/rilpivirine paired with extensive support services for nonsuppressed people with HIV with adherence barriers would likely increase viral suppression and improve survival, researchers found.

Croup symptoms improved when children were exposed to 30 minutes of outdoor cold air in addition to receiving a steroid, according to the results of a randomized controlled trial published in Pediatrics.

Recent data show that more than 6.6 million antibiotics are inappropriately prescribed at dental visits each year, resulting in about $31 million each year in health care costs and out-of-pocket expenses.

A nationally representative survey revealed that of the more than 2 million people with current hepatitis C virus infection, only 68% are aware of their infection.